Skip to main content
Erschienen in: International Urology and Nephrology 10/2017

04.07.2017 | Nephrology - Original Paper

Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients

verfasst von: Ana Paula Silva, Filipa Mendes, Luísa Pereira, André Fragoso, Rui Baptista Gonçalves, Nélio Santos, Fátima Rato, Pedro Leão Neves

Erschienen in: International Urology and Nephrology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The present study aimed at evaluating the relationship between Klotho levels and insulin resistance and albumin-to-creatinine ratio (ACR) in type 2 diabetic patients with CKD.

Methods

We conducted an observational, cross-sectional study in our outpatient diabetic nephropathy clinic from 2014 to 2016, enrolling a total of 107 type 2 diabetic patients with stage 2–3 CKD, with a mean age of 59 years. Several clinical and laboratorial parameters were evaluated, including those related to mineral and carbohydrate metabolism.

Results

The mean eGFR at baseline was 53.2 mL/min, and the mean levels of ACR and Klotho were 181.9 µg/mg and 331.1 pg/m, respectively. In the simple linear regression model, Klotho levels were correlated with age, phosphorus, PTH, ACR, HOMA, IL-6, FGF-23, OxLDL, eGFR and vitamin D levels. Applying a multivariate linear regression model, only the ACR, HOMA-IR, FGF-23 and vitamin D independently influenced the Klotho levels. In the generalized linear model, only the Klotho groups were statistically significant as independent variable (p = 0.007). The results show that the group 1 (<268) compared with group 3 (>440) had higher odds in the higher ACR (≥181), ORa = 3.429, p = 0.014. There were no statistically significant differences between Klotho groups 2 and 3, and the HOMA-IR obtained showed that group 1 (<268) had greater odds of HOMA-IR ≥2 when compared with group 3 (>440), ORa = 21.59, p = 0.017.

Conclusions

Our results showed that Klotho levels are influenced by FGF23, vitamin D and insulin resistance. This suggests that Klotho levels might be affected by renal function as well as having a relevant role on insulin metabolism and ACR homeostasis.
Literatur
1.
Zurück zum Zitat Izquierdo MC, Perez-Gomez MV, Sanchez-Niño MD, Sanz AB, Ruiz-Andres O, Poveda J et al (2012) Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 27(Supple 4):iv6–iv10PubMed Izquierdo MC, Perez-Gomez MV, Sanchez-Niño MD, Sanz AB, Ruiz-Andres O, Poveda J et al (2012) Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 27(Supple 4):iv6–iv10PubMed
2.
Zurück zum Zitat Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R et al (2009) In vivo genetic evidence for Klotho-dependent, fibroblast growth factor 23 (Fgf23)—mediated regulation of systemic phosphate homeostasis. FASEB J 23:433–441CrossRefPubMedPubMedCentral Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R et al (2009) In vivo genetic evidence for Klotho-dependent, fibroblast growth factor 23 (Fgf23)—mediated regulation of systemic phosphate homeostasis. FASEB J 23:433–441CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Bernheim J, Benchetrit S (2011) The potential roles of FGF-23 and Klotho in the prognosis of renal and cardiovascular diseases. Nephrol Dial Transplant 0:1–6 Bernheim J, Benchetrit S (2011) The potential roles of FGF-23 and Klotho in the prognosis of renal and cardiovascular diseases. Nephrol Dial Transplant 0:1–6
4.
Zurück zum Zitat Barker SL, Pastor J, Carranza D, Quiñones H, Griffith C, Goetz R et al (2014) The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Nephrol Dial Transplant 0:1–11 Barker SL, Pastor J, Carranza D, Quiñones H, Griffith C, Goetz R et al (2014) The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Nephrol Dial Transplant 0:1–11
5.
Zurück zum Zitat Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi Nakatani T et al (2001) Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 280:1015–1020CrossRefPubMed Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi Nakatani T et al (2001) Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 280:1015–1020CrossRefPubMed
8.
Zurück zum Zitat Seiler S, Wen M, Roth HJ, Fehrenz M, Flügge F, Herath E et al (2013) Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. Kidney Int 83:121–128CrossRefPubMed Seiler S, Wen M, Roth HJ, Fehrenz M, Flügge F, Herath E et al (2013) Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. Kidney Int 83:121–128CrossRefPubMed
9.
Zurück zum Zitat Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P et al (2005) Suppression of aging in mice by the hormone Klotho. Science 309:1829–1833CrossRefPubMedPubMedCentral Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P et al (2005) Suppression of aging in mice by the hormone Klotho. Science 309:1829–1833CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lin Y, Sun Z (2012) Antiaging gene Klotho Enhances glucose-induced insulin secretion by up-regulating plasma membrane levels of TRPV2 in MIN6 β-cells. Endocrinology 153:3029–3039CrossRefPubMedPubMedCentral Lin Y, Sun Z (2012) Antiaging gene Klotho Enhances glucose-induced insulin secretion by up-regulating plasma membrane levels of TRPV2 in MIN6 β-cells. Endocrinology 153:3029–3039CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez-Larrea C, Jakubowski A et al (2011) The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFkB. J Am Soc Nephrol 22:1315–1325CrossRefPubMedPubMedCentral Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez-Larrea C, Jakubowski A et al (2011) The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFkB. J Am Soc Nephrol 22:1315–1325CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Lim SC, Liu JJ, Subramaniam T, Sum CF (2014) Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 15:487–490CrossRefPubMed Lim SC, Liu JJ, Subramaniam T, Sum CF (2014) Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 15:487–490CrossRefPubMed
13.
Zurück zum Zitat American Diabetes A (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62–S69CrossRef American Diabetes A (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62–S69CrossRef
14.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
15.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filltration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filltration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sawires HK, Essam RM, Morgan MF, Mahmoud RA (2015) Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease. Nephron 129:293–299CrossRefPubMed Sawires HK, Essam RM, Morgan MF, Mahmoud RA (2015) Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease. Nephron 129:293–299CrossRefPubMed
17.
Zurück zum Zitat Kacso IM, Bondor CI, Kacso G (2012) Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. Clin Biochem 45:1415–1420CrossRefPubMed Kacso IM, Bondor CI, Kacso G (2012) Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. Clin Biochem 45:1415–1420CrossRefPubMed
18.
Zurück zum Zitat Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, Sasaki T et al (2007) Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA 104:2331–2336CrossRefPubMedPubMedCentral Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, Sasaki T et al (2007) Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA 104:2331–2336CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Lindberg K, Amin R, Moe OW, Hu MC, Erben RG, Östman Wernerson A et al (2014) The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol 25:2169–2175CrossRefPubMedPubMedCentral Lindberg K, Amin R, Moe OW, Hu MC, Erben RG, Östman Wernerson A et al (2014) The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol 25:2169–2175CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kocełak P, Olszanecka-Glinianowicz M, Chudek J (2012) Fibroblast growth factor 23—structure, function and role in kidney diseases. Adv Clin Exp Med 21:391–401PubMed Kocełak P, Olszanecka-Glinianowicz M, Chudek J (2012) Fibroblast growth factor 23—structure, function and role in kidney diseases. Adv Clin Exp Med 21:391–401PubMed
21.
Zurück zum Zitat Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E et al (2010) FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 78:679–685CrossRefPubMed Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E et al (2010) FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 78:679–685CrossRefPubMed
22.
Zurück zum Zitat Silva AP, Fragoso A, Neves PL (2014) Relationship of vitamin d with diabetes mellitus and diabetic nephropathy. Port J Nephrol Hypertens 28:108–118 Silva AP, Fragoso A, Neves PL (2014) Relationship of vitamin d with diabetes mellitus and diabetic nephropathy. Port J Nephrol Hypertens 28:108–118
23.
Zurück zum Zitat de Zeew D, Agarwal R, AmdahM Audhya P, Coyne D, Garimella T et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study). A randomised controlled trial. Lancet 376:1543–1551CrossRef de Zeew D, Agarwal R, AmdahM Audhya P, Coyne D, Garimella T et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study). A randomised controlled trial. Lancet 376:1543–1551CrossRef
Metadaten
Titel
Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients
verfasst von
Ana Paula Silva
Filipa Mendes
Luísa Pereira
André Fragoso
Rui Baptista Gonçalves
Nélio Santos
Fátima Rato
Pedro Leão Neves
Publikationsdatum
04.07.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 10/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1646-3

Weitere Artikel der Ausgabe 10/2017

International Urology and Nephrology 10/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.